Effectiveness of an Immune-guided Cytomegalovirus Infection Preventive Strategy Compared to a Universal Prophylactic Strategy in Renal Transplant Patients

NCT05708508 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

144

Enrollment

OTHER

Sponsor class

Conditions

Kidney Transplant Infection

Interventions

DRUG: ROVALCYTE

Sponsor

University Hospital, Rouen